fda tirzepatide shortage resolved oct 2 2024 says years-long is resolved, will give limited leeway to compounders is there a tirzepatide shortage

I suspected that these findings would be true based on what I have seen in my patients, and now there are studies to support it, she said

In October 2025, the MHRA dismantled the UKs first illicit weight-loss medicine manufacturing facility, in Northampton, seizing over 2,000 unlicensed retatrutide and tirzepatide pens along with tens of thousands of empty pens ready to be filled

For example, endocrine experts caution that the age-related GH decline might even be protective (theres ongoing debate), and artificially raising hormone levels in someone without deficiency could do more harm than good

M.JohannE.AlexandreE.AntherieuS.AertsH.et al (2017)